Skip to main content
SpringerLink
Log in
Book cover

Biochemical Pharmacology as an Approach to Gastrointestinal Disorders pp 171–185Cite as

Distribution of Muscarinic Receptor mRNAs in the Stomachs of Normal or Immobilized Rats

  • Chapter

  • 118 Accesses

Abstract

Five subtypes of cholinergic muscarinic receptors (M1–M5) have been cloned and characterized by pharmacological and molecular biological methods during the past decade. The M3 subtype was demonstrated in acid-secreting cells, both by functional measurements and binding assays, while the M1 subtype is reported in the intramural ganglionic cells. In the present study, the distribution of M1–M5 mRNAs was mapped by in-situ hybridization histochemistry. Sections (12-µm thick, frozen) from different parts of the stomachs from control or immobilized (3 h immobilization on two consecutive days) rats were hybridized with [35S]UTP labelled ribonucleotides (400–500 nucleotides each) directed to mRNAs of the M1–M5 subtypes. M1 and M3 mRNAs were present in different locations and in different densities in the rat stomach; however, there was a complete lack in detection of mRNAs of the M2, M4 or M5 subtypes. M1 mRNA was found over the enteric ganglionic cells and over some deep epithelial and tunica propria cells of the prepyloric area. No labelling was seen over the epithelial cells of the fundic mucosa. The distribution of M1 mRNA was not changed by immobilization. M3 mRNA was detected over a portion of parietal cells (immunolabelled using a monoclonal antibody) of fundic mucosa and over smooth muscle cells of the tunica muscularis. A large number of tunica propria cells and some enteric ganglions were also labelled for M3 subtype. Weak labelling was seen over the surface mucous cells. The density of the labelling was increased in stressed rats, particularly over the tunica propria cells. These data complete earlier observations obtained by pharmacological and radio ligand binding assays on Ml and M3 subtypes in the rat stomach and support the existence of a non-epithelial, non-neuronal cell regulatory system in the GI tract.

Correspondence

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Spiro HM. Clinical Gastroenterology, 4th edn. New York, USA: McGraw-Hill; 1993: Pt II, 141–72.

    Google Scholar 

  2. Taylor P. Cholinergic agonists. In: Gilman AG, Rail TW, Nies AS, Taylor P, ed. The Pharmacological Basis of Therapeutics, 8th edn. New York, USA: Pergamon Press; 1990: 122–30.

    Google Scholar 

  3. Taylor P. Agents acting at the neuromuscular junction and autonomic ganglia. In: Gilman AG, Rail TW, Nies AS, Taylor P, eds. The Pharmacological Basis of Therapeutics, 8th edn. New York, USA: Pergamon Press; 1990: 166–86.

    Google Scholar 

  4. Goyal RK. Identification, localization and classification of muscarinic receptor subtypes in the gut. Life Sci. 1988; 43: 2209–20.

    Article  PubMed  CAS  Google Scholar 

  5. Hulme EC, Birdsall NJ, Buckley NJ. Muscarinic receptor subtypes. Ann Rev Pharmacol Toxicol. 1990; 30: 633–73.

    Article  CAS  Google Scholar 

  6. Ecknauer R, Thompson WJ, Johnson LR, Rosenfeld GC. Isolated parietal cells: [3H]IQNB binding to putative cholinergic receptors. Am J Physiol. 1980; 239: G204–9.

    PubMed  CAS  Google Scholar 

  7. Black JW, Shankley NP. Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach. Br J Pharmacol. 1985; 86: 609–17.

    Article  PubMed  CAS  Google Scholar 

  8. Soll AH, Berglindh T. Physiology of isolated gastric glands and parietal cells: Receptors and effectors regulating function. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract, 2nd edn. New York, USA: Raven Press; 1987; 883–909.

    Google Scholar 

  9. Pfeiffer A, Rochlitz H, Noelke B et al. Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of M3 type. Gastroenterology. 1990; 98: 218–22.

    Article  PubMed  CAS  Google Scholar 

  10. Pfeiffer A, Hanack C, Kopp R et al. Human gastric mucosa express glandular M3 subtype of muscarinic receptors. Dig Dis Sci. 1990; 35: 1468–72.

    Article  PubMed  CAS  Google Scholar 

  11. Van der Zee EA, Buwalda B, Strubbe JH, Strosberg AD, Luiten PG. Immunocytochemical localization of muscarinic acetylcholine receptors in the rat endocrine pancreas. Cell Tissue Res. 1992; 269: 99–106.

    Article  PubMed  Google Scholar 

  12. Kajimura M, Reuben A, Sachs G. The muscannic receptor gene expressed in rabbit parietal cells is the m3 subtype. Gastroenterology. 1992; 103: 870–5.

    PubMed  CAS  Google Scholar 

  13. Culp DJ, Wolosin JM, Soil AH, Forte JG. Muscarinic receptors and guanylate cyclase in mammalian gastric glandular cells. Am J Physiol. 1983; 245: G641–6.

    Google Scholar 

  14. Sue R, Toomey ML, Todisco A, Soll AH, Yamada T. Pirenzepine-sensitive muscarinic receptors regulate gastric somatostatin and gastrin. Am J Physiol. 1985; 248: G184–7.

    PubMed  CAS  Google Scholar 

  15. Yamada T, Soll AH, Park J, Elashoff J. Autonomic regulation of somatostatin release: studies with primary cultures of canine fundic mucosal cells. Am J Physiol. 1984; 247: G567–73.

    PubMed  CAS  Google Scholar 

  16. Angus JA, Black JW. The interaction of choline esters, vagal stimulation and H2-receptor blockade on acid secretion in vitro. Fur J Pharmacol. 1982; 80: 217–24.

    CAS  Google Scholar 

  17. Black JW, Leff P, Shankley NP. Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay. Br 7 Pharmacol. 1985; 86: 581–7.

    CAS  Google Scholar 

  18. Sandvik AK, Kleveland PM, Waldum HL. Muscarinic M2 stimulation releases histamine in the totally isolated, vascularly perfused rat stomach. Scand J Gastroenterol. 1988; 23: 1049–56.

    Article  PubMed  CAS  Google Scholar 

  19. Gerber JG, Payne NA. The role of gastric secretagogues in regulating gastric histamine release in vivo. Gastroenterology. 1992; 102: 403–8.

    PubMed  CAS  Google Scholar 

  20. Ruoff HJ, Fladung B, Demol P, Weihrauch TR. Gastrointestinal receptors and drugs in motility disorders. Digestion. 1991; 48: 1–17.

    Article  PubMed  CAS  Google Scholar 

  21. Ladinsky H, Giraldo E, Monferini E et al. Muscarinic receptor heterogeneity in smooth muscle: binding and functional studies with AF-DX 116. Trends Pharmacol Sci. 1988;Supp1:44:44–8.

    Google Scholar 

  22. Hanack C, Pfeiffer A. Upper gastrointestinal porcine smooth muscle expresses M2- and M3 receptors. Digestion. 1990; 45: 196–201.

    Article  PubMed  CAS  Google Scholar 

  23. Bellido J, Fernandez JL, Gomez A, Sanchez de la Cuesta F. Otenzepad shows two populations of binding sites in human gastric smooth muscle. Can J Physiol Pharmacol. 1995; 73: 124–9.

    Article  PubMed  CAS  Google Scholar 

  24. Kilbinger H, Nafziger M. Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol. 1985; 328: 304–9.

    Article  PubMed  CAS  Google Scholar 

  25. North RA, Suprenant A. Muscarinic receptors on neurones of the submucous plexus. In: Lux G, Daniel EE, eds. Muscarinic Receptor Subtypes in the GI Tract. Berlin: Springer-Verlag;1985:28–32.

    Chapter  Google Scholar 

  26. Dammann F, Fuder H, Giachetti A, Giraldo E, Kilbinger H, Micheletti R. AF-DX 116 differentiates between prejunctional muscarinic receptors located on noradrenergic and cholinergic nerves. Naunyn Schmiedebergs Arch Pharmacol. 1989; 339: 268–71.

    Article  PubMed  CAS  Google Scholar 

  27. Soejima O, Katsuragi T, Furukawa T. Opposite modulation by muscarinic M1 and M3 receptors of acetylcholine release from guinea pig ileum as measured directly. Eur J Pharmacol. 1993; 249: 1–6.

    Article  PubMed  CAS  Google Scholar 

  28. Dietrich C, Kilbinger. Prejunctional M1 and postjunctional M3 muscarinic receptors in the circular muscle of the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol. 1995; 351: 237–43.

    Article  PubMed  CAS  Google Scholar 

  29. Kubo T, Fukuda K, Mikami A et al. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature. 1986; 323: 411–16.

    Article  PubMed  CAS  Google Scholar 

  30. Kubo T, Maeda A, Sugimoto K et al. Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett. 1986; 209: 367–72

    Article  PubMed  CAS  Google Scholar 

  31. Bonner TI, Buckley NJ, Young AC, Brann MR. Identification of a family of muscarinic acetylcholine receptor genes [published erratum appears in Science. 1987;237(4822):237]. Science. 1987; 237: 527–32.

    Article  PubMed  CAS  Google Scholar 

  32. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J. 1987; 6: 3923–9.

    PubMed  CAS  Google Scholar 

  33. Bonner TI, Young AC, Brann MR, Buckley NJ. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron. 1988; 1: 403–10.

    Article  PubMed  CAS  Google Scholar 

  34. Bonner TI. The molecular basis of muscarinic receptor diversity. Trends Neurol Sci. 1989; 12: 148–51.

    Article  CAS  Google Scholar 

  35. Buckley NJ, Bonner TI, Buckley CM, Brann MR. Antagonist binding properties of five cloned muscarmic receptors expressed in CHO-Kl cells. Mol Pharmacol. 1989; 35: 469–76.

    PubMed  CAS  Google Scholar 

  36. Boddeke HW, Buttini M. Pharmacological properties of cloned muscarinic receptors expressed in A9 cells; comparison with in vitro models. Eur J Pharmacol. 1991; 202: 151–7.

    Article  PubMed  CAS  Google Scholar 

  37. Miller JH, Gibson VA, McKinney M. Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors. J Pharmacol Exp Ther. 1991; 259: 601–7.

    PubMed  CAS  Google Scholar 

  38. Dong GZ, Kameyama K, Rinken A, Haga T. Ligand binding properties of muscarinic acetylcholine receptor subtypes (ml—m5) expressed in baculovirus-infected insect cells. J Pharmacol Exp Ther. 1995; 274: 378–84.

    PubMed  CAS  Google Scholar 

  39. Ashkenazi A, Winslow JW, Peralta EF et al. An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science. 1987; 238: 672–5.

    Article  PubMed  CAS  Google Scholar 

  40. Conklin BR, Brann MR, Buckley NJ, Ma AL, Bonner TI, Axelrod J. Stimulation of arachidonic acid release and inhibition of mitogenesis by cloned genes for muscarinic receptor subtypes stably expressed in A9 L cells. Pry Natl Acad Sci USA. 1988; 85: 8698–702.

    Article  CAS  Google Scholar 

  41. Pinkas-Kramarski R, Stein R, Zimmer Y, Sokolovsky M. Cloned rat M3 muscarinic receptors mediate phosphoinositide hydrolysis but not adenylate cyclase inhibition. FEBS Lett. 1988; 239: 174–8.

    Article  PubMed  CAS  Google Scholar 

  42. Stein R, Pinkas-Kramarski R, Sokolovsky M. Cloned M1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnover. EMBO J. 1988; 7: 3031–5.

    PubMed  CAS  Google Scholar 

  43. Jones SV, Barker JL, Buckley NJ, Bonner TI, Collins RM, Brann MR. Cloned muscarinic receptor subtypes expressed in A9 L cells differ in their coupling to electrical responses. Mol Pharmacol. 1988; 34: 421–6.

    PubMed  CAS  Google Scholar 

  44. Bujo H, Nakai J, Kubo T et al. Different sensitivities to agonist of muscarinic acetylcholine receptor subtypes. FEES Lett. 1988; 240: 95–100.

    Article  CAS  Google Scholar 

  45. Fukuda K, Kubo T, Maeda A et al. Selective effector coupling of muscarinic acetylcholine receptor subtypes. Trends Pharmacol Sci. 1989;Supp1:4–10.

    Google Scholar 

  46. Maeda A, Kubo T, Mishina M, Numa S. Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes. FEBS Lett. 1988; 239: 339–42.

    Article  PubMed  CAS  Google Scholar 

  47. Mezey E, Palkovits M. Localization of targets for anti-drugs in cells of the immune system [see comments]. Science. 1992; 258: 1662–5.

    Article  PubMed  CAS  Google Scholar 

  48. Mezey E, Hoffman BJ, Harta G, Palkovits M, Northup J. Potential problems in using [35S]-dATPtailed oligonucleotides for detecting mRNAs in certain cells of the immune system. J Histochem Cytochem. 1994; 42: 1277–83.

    Article  PubMed  CAS  Google Scholar 

  49. Pare WP, Glavin GB. Restraint stress in biomedical research: a review. Neurosci Biobehav Rev. 1986; 10: 339–70.

    Article  PubMed  CAS  Google Scholar 

  50. Young S. In situ hybridization histochemical detection of neuropeptide mRNA using DNA and RNA probes. Meth Enzymol. 1989; 168: 702–10.

    Article  PubMed  CAS  Google Scholar 

  51. Bradley DJ, Towle HC, Young WS. Spatial and temporal expression of alpha-and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J Neurosci. 1992; 12: 2288–302.

    PubMed  CAS  Google Scholar 

  52. Smolka A, Swiger KM. Site-directed antibodies as topographical probes of the gastric II,K-ATPase alpha-subunit. Biochim Biophys Acta. 1992; 1108: 75–85

    Article  PubMed  CAS  Google Scholar 

  53. Weiner DM, Levey AI, Brann MR. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Nat ’ Acad Sci USA. 1990; 87: 7050–4.

    Article  CAS  Google Scholar 

  54. Baumgold J, Drobnick A. An agonist that is selective for adenylate cyclase-coupled muscarinic receptors. Mol Pharmacol. 1989; 36: 465–70.

    PubMed  CAS  Google Scholar 

  55. Wess J, Lambrecht G, Mutschler E, Brann MR, Dorje F. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations. Br J Pharmacol. 1991;102:246–50.

    Article  PubMed  CAS  Google Scholar 

  56. Wilkes JM, Kajimura M, Scott DR, Hersey SJ, Sachs G. Muscarinic responses of gastric parietal cells. J MembBiol. 1991; 122: 97–110.

    CAS  Google Scholar 

  57. Aagaard P, McKinney M. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors. J Pharmacol Exp Ther. 1993; 267: 1478–83.

    PubMed  CAS  Google Scholar 

  58. Howell RE, Laemont KD, Kovalsky MP et al. Pulmonary pharmacology of a novel, smooth muscle-selective muscarinic antagonist in vivo. J Pharmacol Exp Ther. 1994; 270: 546–53.

    PubMed  CAS  Google Scholar 

  59. Doods H, Entzeroth M, Mayer N. Cardioselectivity of AQ-RA 741, a novel tricyclic antimuscarinic drug. Eur J Pharmacol. 1991; 192: 147–52.

    Article  PubMed  CAS  Google Scholar 

  60. Shannon HE, Bymaster FP, Calligaro DO et al. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors. J Pharmacol Exp Ther. 1994; 269: 271–81.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute of Mental Health, USA

    B. Hunyady & M. Palkovits

  2. National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA

    É. Mezey, K. Pacak & Gy. Harta

  3. First Department of Medicine, Medical University of Pécs, Pécs, Hungary

    B. Hunyady

Authors
  1. B. Hunyady
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. É. Mezey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Pacak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gy. Harta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Palkovits
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Pharmacy, University of Wisconsin, Madison, WI, USA

    Timothy S. Gaginella

  2. First Department of Medicine, University Medical School of Pécs, Pécs, Hungary

    Gyula Mózsik

  3. Department of Biomedical Sciences, Sheffield Hallam University, Sheffield, UK

    K. D. Rainsford

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Hunyady, B., Mezey, É., Pacak, K., Harta, G., Palkovits, M. (1997). Distribution of Muscarinic Receptor mRNAs in the Stomachs of Normal or Immobilized Rats. In: Gaginella, T.S., Mózsik, G., Rainsford, K.D. (eds) Biochemical Pharmacology as an Approach to Gastrointestinal Disorders. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5390-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5390-4_15

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6267-1

  • Online ISBN: 978-94-011-5390-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation